Financials
Financial year 2026
KANEKA MEDICAL EUROPE from Zaventem, company number BE0453722745, closed financial year 2026 with a result of € 3.7 million after tax. For that financial year KANEKA MEDICAL EUROPE recorded revenue of € 58 million and equity of € 28.4 million. Compared with financial year 2025, the result moved from € 4.3 million to € 3.7 million. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.
€ 28.4 million
▲ 7% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 3.7 million
▼ 15% vs 2025
Profit after tax over the fiscal year.
€ 86,175
▼ 84% vs 2025
Cash and bank balances on the last day of the fiscal year.
€ 1.9 million paid out
50 % of the profit went to the shareholders, mostly to Kaneka Europe Holding Company NV (100 % of the shares). That is where the money ends up.
People and assets in 2026
7
▲ 0.4 vs 2025
Average over the fiscal year, from the social balance sheet.
€ 5.4 million
▼ 2% vs 2025
€ 776,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 613,552
▲ 18% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 12.8 million
▲ 6% vs 2025
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 98 days on average.
€ 993,228
▼ 11% vs 2025
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Revenue | € 48,656,128 | € 46,102,574 | € 52,736,755 | € 58,033,993 | ▲ 10% |
| Profit after taxes | € 4,170,500 | € 4,820,449 | € 4,349,083 | € 3,710,633 | ▼ 15% |
| Equity | € 21,921,953 | € 24,332,177 | € 26,506,719 | € 28,362,035 | ▲ 7% |
| Total debts | € 13,619,106 | € 11,705,176 | € 16,451,176 | € 16,673,214 | ▲ 1% |
| Cash | € 287,709 | € 468,231 | € 525,279 | € 86,175 | ▼ 84% |
| Land & buildings | € 57,890 | € 55,628 | € 53,366 | € 51,110 | ▼ 4% |
| Retained profit | € 13,462,906 | € 15,873,130 | € 18,047,672 | € 19,902,988 | ▲ 10% |
| Dividend | € 2,085,250 | € 2,410,224 | € 2,174,542 | € 1,855,317 | ▼ 15% |
| Balance sheet total | € 35,541,058 | € 36,037,353 | € 42,957,894 | € 45,083,794 | ▲ 5% |
| Employees (FTE) | 6 | 6.6 | 6.6 | 7 | ▲ 0.4 |
Key figures of KANEKA MEDICAL EUROPE, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to KANEKA MEDICAL EUROPE?
What happened at KANEKA MEDICAL EUROPE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Masaaki Kimura stepped down as director. NBB
- Masanobu Sugawara stepped down as director. NBB
- Kan Okabe stepped down as director. NBB
- New annual accounts for financial year 2026: profit of € 3.7 million (▼ 15% vs 2025). Source: NBB ↗
- Masanobu Sugawara became a director. NBB
- Kan Okabe became a director. NBB
- New establishment in Westerlo. KBO
- Masaaki Kimura became a director. NBB
In short
From € 4.2 million profit in 2023 to € 3.7 million profit in 2026.
Paid € 6 million in corporate taxes since 2023.
Best year ever: 2024, with € 4.8 million profit.
Paid out € 8.5 million in dividends to the owners in total.
A new publication or filing at KANEKA MEDICAL EUROPE? We notify you, reason included.
Follow KANEKA MEDICAL EUROPEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The shares are held by Kaneka Europe Holding Company NV (100%).
Directors
According to the 2026 annual accounts
Masaaki Kimura
Director
since 2021 · until 2028
Masanobu Sugawara
Director
since 2022 · until 2028
since 2022 · until 2028
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Lenneke Marelaan 4
1932 Zaventem
Nijverheidsstraat 16
2260 Westerlo
Active since 29 October 2021
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0453.722.745
- VAT number
- BE 0453.722.745
- Registered office
- Lenneke Marelaan 4, 1932 Zaventem
- Names & denominations
- KANEKA MEDICAL EUROPE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 31 October 1994
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Detailhandel in medische en orthopedische artikelen
Vervaardiging van overige farmaceutische producten
Vervaardiging van geneesmiddelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels